← IOVANCE BIOTHERAPEUTICS, INC.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||
| Current assets: | |||||||||||
| Cash and Cash Equivalents, at Carrying Value | $106.7m | $145.4m | $82.2m | $14.0m | $67.3m | $78.2m | $231.7m | $114.9m | $115.7m | $163.1m | |
| Prepaid Expense and Other Assets, Current | $3.0m | $3.9m | $6.9m | $9.4m | $6.7m | $3.5m | $7.3m | $17.5m | $12.4m | $11.6m | |
| Cash, Cash Equivalents, and Short-term Investments | $166.5m | — | $386.4m | — | $635.0m | — | — | — | — | — | |
| Short-term Investments | $59.8m | $0 | $386.4m | $293.1m | $562.1m | $426.2m | $240.1m | $165.0m | $208.1m | $133.9m | |
| Inventory, Net | — | — | — | — | — | — | — | $10.4m | $51.5m | $51.7m | |
| Assets, Current | $169.5m | $149.3m | $475.4m | $316.5m | $636.1m | $508.0m | $479.1m | $307.8m | $457.0m | $442.7m | |
| Property, Plant and Equipment, Net | $2.4m | $2.5m | $2.7m | $8.5m | $59.2m | $100.9m | $105.2m | $114.0m | $109.1m | $131.1m | |
| Operating Lease, Right-of-Use Asset | — | — | — | $10.7m | $54.8m | $69.0m | $73.0m | $62.5m | $55.2m | $45.9m | |
| Other Assets, Noncurrent | — | $3.6m | $2.8m | $3.5m | $12.9m | $1.8m | $189k | $270k | $369k | $8.2m | |
| Additional Financial Items | |||||||||||
| Accounts Receivable, after Allowance for Credit Loss, Current | — | — | — | — | — | — | — | $151k | $69.3m | $82.4m | |
| Accrued Liabilities, Current | $4.1m | $8.7m | $11.7m | $16.3m | $35.1m | $56.8m | $52.3m | $69.4m | $81.9m | $111.2m | |
| Assets | $171.9m | $155.4m | $480.8m | $344.7m | $768.5m | $777.3m | $664.0m | $780.4m | $910.4m | $913.2m | |
| LIABILITIES AND EQUITY | |||||||||||
| Current liabilities: | |||||||||||
| Operating Lease, Liability, Current | — | — | — | $7.3m | $6.3m | $5.1m | $12.6m | $7.8m | $12.9m | $4.0m | |
| Accounts Payable, Current | $863k | $1.2m | $2.7m | $15.6m | $13.5m | $27.4m | $26.6m | $33.1m | $27.5m | $22.2m | |
| Operating Lease, Liability, Noncurrent | — | — | — | $4.2m | $45.4m | $65.5m | $71.9m | $67.1m | $44.4m | $44.4m | |
| Liabilities, Current | $5.0m | $9.9m | $14.4m | $39.1m | $54.9m | $89.2m | $91.5m | $110.3m | $122.3m | $138.4m | |
| Deferred Income Tax Liabilities, Net | — | — | — | — | — | — | — | $17.3m | $32.3m | $31.8m | |
| Other Liabilities, Noncurrent | — | — | — | $2.4m | $11.7m | — | — | — | — | — | |
| Deferred Tax Liabilities, Net | — | — | — | — | — | — | — | $17.3m | $32.3m | $31.8m | |
| Liabilities | — | — | $14.6m | $45.7m | $112.0m | $155.7m | $164.3m | $195.7m | $200.0m | $214.6m | |
| Stockholders’ equity: | |||||||||||
| Common Stock, Value, Issued | $3k | $3k | $5k | $5k | $6k | $7k | $8k | $11k | $13k | $17k | |
| Additional Paid in Capital | $324.0m | $394.7m | $839.0m | $869.4m | $1.5b | $1.8b | $2.1b | $2.6b | $3.1b | $3.5b | |
| Retained Earnings (Accumulated Deficit) | ($157.1m) | ($249.2m) | ($372.8m) | ($570.6m) | ($830.2m) | ($1.2b) | ($1.6b) | ($2.0b) | ($2.4b) | ($2.8b) | |
| Accumulated Other Comprehensive Income (Loss), Net of Tax | $29k | $0 | ($42k) | $220k | $19k | ($601k) | ($902k) | $2.5m | ($1.0m) | $16.4m | |
| Stockholders' Equity Attributable to Parent | $166.9m | $145.5m | $466.2m | $299.0m | $656.5m | $621.7m | $499.6m | $584.6m | $710.4m | $698.6m | |
| Liabilities and Equity | $171.9m | $155.4m | $480.8m | $344.7m | $768.5m | $777.3m | $664.0m | $780.4m | $910.4m | $913.2m |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.